Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

Update from ESGO 2026 PYNNACLE Phase 2 study: Interim results from the ovarian cancer cohort Evaluating a first-in-class p53 reactivator, rezatapopt*, in TP53 Y220C–mutant advanced solid tumours 📺 Clinical insights and expert discussion from Profs Domenica Lorusso and Jean-Sebastien Frenel This programme has been sponsored by PMV Pharma and...

COR2EDMedEd's profile picture

COR2ED

1,616 subscribers

5,788,569 görüntüleme • 4 ay önce •via X (Twitter)

Sağlık & İyilikEğitimBilim & Teknoloji
LIVE

Anya Rossi• Live Now

Private livecam show

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

Update on the PYNNACLE Phase 2 initial analysis at AACR–NCI–EORTC 2025 Evaluating rezatapopt, a first-in-class p53 reactivator, as a treatment for TP53 Y220C–mutant locally advanced and metastatic solid tumours Watch the video for expert insights from Drs Alison Schram (Alison Schram) and Elena Garralda *Rezatapopt is an investigational agent which is not approved by a regulatory agency This programme has been sponsored by PMV Pharma
6:26

Update on the PYNNACLE Phase 2 initial analysis at AACR–NCI–EORTC 2025 Evaluating rezatapopt, a first-in-class p53 reactivator, as a treatment for TP53 Y220C–mutant locally advanced and metastatic solid tumours Watch the video for expert insights from Drs Alison Schram (Alison Schram) and Elena Garralda *Rezatapopt is an investigational agent which is not approved by a regulatory agency This programme has been sponsored by PMV Pharma

COR2ED

710,044 görüntüleme • 8 ay önce

ER+/HER2- metastatic breast cancer: Highlights from APBCS 2026 Satellite Symposium, chaired by Dr Mastura Md Yusof 📺 Experts discuss 2L+ treatment strategies in endocrine therapy-eligible patients From Dr Hope S. Rugo (Hope Rugo) and Prof. Matteo Lambertini (Matteo Lambertini, MD PhD) This programme has been sponsored by Menarini Stemline and is intended for HCPs only. Brought to you by COR2ED Medical Affairs
4:58

ER+/HER2- metastatic breast cancer: Highlights from APBCS 2026 Satellite Symposium, chaired by Dr Mastura Md Yusof 📺 Experts discuss 2L+ treatment strategies in endocrine therapy-eligible patients From Dr Hope S. Rugo (Hope Rugo) and Prof. Matteo Lambertini (Matteo Lambertini, MD PhD) This programme has been sponsored by Menarini Stemline and is intended for HCPs only. Brought to you by COR2ED Medical Affairs

COR2ED

7,632,504 görüntüleme • 4 ay önce

Update from ESMO 2025! >> Endometrial & ovarian cancer highlights 📺 Prof. Nicoletta Colombo reviews the latest data in gynecological cancers presented at the congress Could these developments impact clinical practice? Watch to find out! Endorsed by ICAN, International Cancer Advocacy Network This independent programme is supported by COR2ED
5:30

Update from ESMO 2025! >> Endometrial & ovarian cancer highlights 📺 Prof. Nicoletta Colombo reviews the latest data in gynecological cancers presented at the congress Could these developments impact clinical practice? Watch to find out! Endorsed by ICAN, International Cancer Advocacy Network This independent programme is supported by COR2ED

COR2ED

114,711 görüntüleme • 8 ay önce

🧬 What do HCPs need to know about current treatment options for advanced/recurrent EndometrialCancer? An animated MedEd video from Prof. Christian Marth 📺 Hear about 👉 A patient case study 👉 Latest treatment strategies 👉 A shift from traditional chemotherapy to personalised therapies driven by molecular profiling. This educational programme is sponsored by an Independent Educational Grant from Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of or speakers involved in this programme.
7:36

🧬 What do HCPs need to know about current treatment options for advanced/recurrent EndometrialCancer? An animated MedEd video from Prof. Christian Marth 📺 Hear about 👉 A patient case study 👉 Latest treatment strategies 👉 A shift from traditional chemotherapy to personalised therapies driven by molecular profiling. This educational programme is sponsored by an Independent Educational Grant from Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of or speakers involved in this programme.

OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED

240,514 görüntüleme • 1 yıl önce

🧬 What do HCPs need to know about current treatment options for advanced/recurrent #EndometrialCancer? An animated #MedEd video from Prof. Christian Marth 📺 Hear about 👉 A patient case study 👉 Latest treatment strategies 👉 A shift from traditional chemotherapy to personalised therapies driven by molecular profiling. This educational programme is sponsored by an Independent Educational Grant from Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of or speakers involved in this programme. #Oncology #GynecologicCancer
7:36

🧬 What do HCPs need to know about current treatment options for advanced/recurrent #EndometrialCancer? An animated #MedEd video from Prof. Christian Marth 📺 Hear about 👉 A patient case study 👉 Latest treatment strategies 👉 A shift from traditional chemotherapy to personalised therapies driven by molecular profiling. This educational programme is sponsored by an Independent Educational Grant from Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of or speakers involved in this programme. #Oncology #GynecologicCancer

OBSTETRICS & GYNECOLOGY CONNECT

462,512 görüntüleme • 1 yıl önce

Just released! Bladder cancer update from ESMO 25 📺 Prof. Thomas Powles shares his bladder cancer highlights & reviews the latest data from KEYNOTE-905, ALBAN & Imvigor011. This independent programme is supported by COR2ED
4:24

Just released! Bladder cancer update from ESMO 25 📺 Prof. Thomas Powles shares his bladder cancer highlights & reviews the latest data from KEYNOTE-905, ALBAN & Imvigor011. This independent programme is supported by COR2ED

COR2ED

229,737 görüntüleme • 8 ay önce

Today at #ASCO26, in collaboration with Moderna, we're proud to present five-year follow-up results from a Phase 2b study evaluating our investigational individualized neoantigen therapy for #melanoma. Learn more:
0:31

Today at #ASCO26, in collaboration with Moderna, we're proud to present five-year follow-up results from a Phase 2b study evaluating our investigational individualized neoantigen therapy for #melanoma. Learn more:

Merck

13,665 görüntüleme • 1 ay önce

Pre-analytical phase challenges & biomarker testing in HER2+ metastatic breast cancer From Prof. Gary Tse, Dr Carlos Barrios, & Oncology Brothers Highlights in this video 📹 >> Endorsed by Biomarker Collaborative Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.
5:46

Pre-analytical phase challenges & biomarker testing in HER2+ metastatic breast cancer From Prof. Gary Tse, Dr Carlos Barrios, & Oncology Brothers Highlights in this video 📹 >> Endorsed by Biomarker Collaborative Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

BREAST CANCER CONNECT powered by COR2ED

15,219,176 görüntüleme • 17 gün önce

We are the first hospital in Europe to deliver a new non-invasive cancer treatment to a patient outside of a clinical trial, after being fast-tracked by Department of Health and Social Care. This has been made possible by funding from a generous donation to Cambridge University from LiKaShing Foundation and Addenbrooke's Charity.
0:51

We are the first hospital in Europe to deliver a new non-invasive cancer treatment to a patient outside of a clinical trial, after being fast-tracked by Department of Health and Social Care. This has been made possible by funding from a generous donation to Cambridge University from LiKaShing Foundation and Addenbrooke's Charity.

Cambridge University Hospitals NHS

25,380 görüntüleme • 8 ay önce

Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC) >> This is a rare and complex cancer that needs early diagnosis and intervention 📺 Watch the video from Meredith Cummins, INCA President-Elect, and CEO of NeuroEndocrine Cancer Australia, to find out: -Why urgency is needed in diagnosis & treatment -The potential of investigational treatments -Where to find support Endorsed by: INCA (NET Cancer Day). NeuroEndocrine Cancer Australia, Neuroendocrine Cancer UK #NotJustNECancer, Neuroendocrine Cancer Foundation, Neuroendocrine Cancer Research Foundation & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim
5:45

Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC) >> This is a rare and complex cancer that needs early diagnosis and intervention 📺 Watch the video from Meredith Cummins, INCA President-Elect, and CEO of NeuroEndocrine Cancer Australia, to find out: -Why urgency is needed in diagnosis & treatment -The potential of investigational treatments -Where to find support Endorsed by: INCA (NET Cancer Day). NeuroEndocrine Cancer Australia, Neuroendocrine Cancer UK #NotJustNECancer, Neuroendocrine Cancer Foundation, Neuroendocrine Cancer Research Foundation & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim

COR2ED

757,945 görüntüleme • 5 ay önce

🔥🚨BREAKING NEWS: Big Pharma is being exposed about an underground cancer cure happening in Mexico that is being censored and hidden by Pharmaceutical companies that benefit from chemotherapy. Ty and Charlene Bollinger are going viral for revealing how Chemotherapy started from Mustard gas and the doctors that died trying to save lives by telling the ‘truth’ about cancer. This new footage also reveals how Big Pharma is secretly "ghostwriting" articles in top medical and oncology journals and how medical doctors receive almost zero education on nutrition during medical school. It is time the cancer narrative starts getting exposed. Episode 1 of ‘A Global Quest’ is titled “The True History of Chemotherapy & The Pharmaceutical Monopoly” Check the comment below for the full docuseries expose’
0:43

🔥🚨BREAKING NEWS: Big Pharma is being exposed about an underground cancer cure happening in Mexico that is being censored and hidden by Pharmaceutical companies that benefit from chemotherapy. Ty and Charlene Bollinger are going viral for revealing how Chemotherapy started from Mustard gas and the doctors that died trying to save lives by telling the ‘truth’ about cancer. This new footage also reveals how Big Pharma is secretly "ghostwriting" articles in top medical and oncology journals and how medical doctors receive almost zero education on nutrition during medical school. It is time the cancer narrative starts getting exposed. Episode 1 of ‘A Global Quest’ is titled “The True History of Chemotherapy & The Pharmaceutical Monopoly” Check the comment below for the full docuseries expose’

Dom Lucre | Breaker of Narratives

2,736,994 görüntüleme • 1 yıl önce

As promised here is a video of NES GLUG by Paul Proctor which I rescued recently from his development disks. This is the first time this has been seen by anyone apart from a few close friends and the Stampers at RARE. His disks were in a bad state and needed a deep clean.
2:06

As promised here is a video of NES GLUG by Paul Proctor which I rescued recently from his development disks. This is the first time this has been seen by anyone apart from a few close friends and the Stampers at RARE. His disks were in a bad state and needed a deep clean.

Kevin Edwards ( Retro Videogame development )

35,101 görüntüleme • 1 yıl önce

#WATCH | "This ethanol blending in petrol has been not done overnight. It is a measured, scientifically driven, step-by-step process. In 2013 and 2014, we were blending about one and a half percent ethanol in gasoline. And this programme was targeted to have 20% blending, which is E20, completed in December 25, five years ahead of the target. This programme, the ethanol blending programme, particularly in 2018, was in a structured manner, put out for discussion and deliberation by all stakeholders. It is supported by scientific evidence, extensive testing by the automotive, manufacturers and the agencies who support them, namely the Automotive Research Association of India, ARAI and SIAM, and also it is in line with the global best practices which is followed to green the fossil fuels to lower the carbon emissions," says expert Vartika Shukla at the press conference by industry experts on ethanol. PIB India Ministry of Information and Broadcasting Ministry of Petroleum and Natural Gas #MoPNG
1:35

#WATCH | "This ethanol blending in petrol has been not done overnight. It is a measured, scientifically driven, step-by-step process. In 2013 and 2014, we were blending about one and a half percent ethanol in gasoline. And this programme was targeted to have 20% blending, which is E20, completed in December 25, five years ahead of the target. This programme, the ethanol blending programme, particularly in 2018, was in a structured manner, put out for discussion and deliberation by all stakeholders. It is supported by scientific evidence, extensive testing by the automotive, manufacturers and the agencies who support them, namely the Automotive Research Association of India, ARAI and SIAM, and also it is in line with the global best practices which is followed to green the fossil fuels to lower the carbon emissions," says expert Vartika Shukla at the press conference by industry experts on ethanol. PIB India Ministry of Information and Broadcasting Ministry of Petroleum and Natural Gas #MoPNG

DD News

24,664 görüntüleme • 5 gün önce

VIDEO | Delhi: In her opening remarks at the press conference by industry experts on ethanol, expert Vartika Shukla says, "This ethanol blending in petrol has been not done overnight. It is a measured, scientifically driven, step-by-step process. In 2013 and 2014, we were blending about one and a half percent ethanol in gasoline. And this programme was targeted to have 20% blending, which is E20, completed in December 25, five years ahead of the target. This programme, the ethanol blending programme, particularly in 2018, was in a structured manner, put out for discussion and deliberation by all stakeholders. It is supported by scientific evidence, extensive testing by the automotive, manufacturers and the agencies who support them, namely the Automotive Research Association of India, ARAI and SIAM, and also it is in line with the global best practices which is followed to green the fossil fuels to lower the carbon emissions." (Full video available on PTI Videos -
1:32

VIDEO | Delhi: In her opening remarks at the press conference by industry experts on ethanol, expert Vartika Shukla says, "This ethanol blending in petrol has been not done overnight. It is a measured, scientifically driven, step-by-step process. In 2013 and 2014, we were blending about one and a half percent ethanol in gasoline. And this programme was targeted to have 20% blending, which is E20, completed in December 25, five years ahead of the target. This programme, the ethanol blending programme, particularly in 2018, was in a structured manner, put out for discussion and deliberation by all stakeholders. It is supported by scientific evidence, extensive testing by the automotive, manufacturers and the agencies who support them, namely the Automotive Research Association of India, ARAI and SIAM, and also it is in line with the global best practices which is followed to green the fossil fuels to lower the carbon emissions." (Full video available on PTI Videos -

Press Trust of India

98,876 görüntüleme • 5 gün önce

THIS IS WHAT CHURCH IS ALL ABOUT! FROM BEING BROUGHT IN CHAINS TO LEARNING A SKILL, OPENING A BUSINESS AND BEING SPONSORED IN THE UNIVERSITY BY DRS PASTORS PAUL AND BECKY PAUL-ENENCHE - Testimony by Sis. Faith Adama #DrPaulEnenche #DrMrsBeckyPaulEnenche #DIGC #Dominion2025 #GloryDome #SupersonicSunday #23rdMarch2025 #ChurchGist
2:26

THIS IS WHAT CHURCH IS ALL ABOUT! FROM BEING BROUGHT IN CHAINS TO LEARNING A SKILL, OPENING A BUSINESS AND BEING SPONSORED IN THE UNIVERSITY BY DRS PASTORS PAUL AND BECKY PAUL-ENENCHE - Testimony by Sis. Faith Adama #DrPaulEnenche #DrMrsBeckyPaulEnenche #DIGC #Dominion2025 #GloryDome #SupersonicSunday #23rdMarch2025 #ChurchGist

therealchurchgist

13,362 görüntüleme • 1 yıl önce

Toby Rogers, PhD gives a 360° explanation for why autism hasn't been studied correctly, as medicine, research, & regulation have all been captured by Big Pharma money. 🔥"Doctors live inside an epistemic bubble engineered by the pharmaceutical industry to increase its profits" Per Children's Health Defense: "Rogers is a fellow with the Brownstone Institute for Social and Economic Research. He has a doctorate in political economy from the University of Sydney in Australia, and a Master of Public Policy from the University of California, Berkeley." ---------------Partial transcription of clip-------------- "Let me explain how all this works. This is right in my wheelhouse. This is what I study. I follow the money. Autism is a political economy problem. These are all political economy problems. "Thus far, government has failed in response to the autism epidemic because of regulatory capture. Rather than protecting public health, regulators have advanced the interests of the pharmaceutical industry. That's pretty straightforward. Science and medicine have failed in response to the autism epidemic because of epistemic capture. And what I mean by that is that the pharmaceutical industry has captured every step in the knowledge production process in science and medicine. "Big Pharma controls what is studied, how it is researched, and what qualifies as evidence. Now, this capture permeates every level of the system. Medical textbooks and curricula are influenced by financially conflicted academics. Universities and department chairs hold substantial pharmaceutical ties. "Most clinical trials are conducted by for profit contract research organizations. In China and the third world, a large share of scientific journal articles are ghostwritten. The pharmaceutical industry spends over $27 billion annually on drug promotion and continuing medical education. Standards of care are, authored by conflicted physicians. So from the first day of medical school to the final years of practice, doctors live inside an epistemic bubble engineered by the pharmaceutical industry to increase its profits. "Senator Blumenthal and Dr. Scott only pay attention to captured science. Science that's controlled by the pharmaceutical industry. The correct answers, the best science is happening outside of that epistemic bubble. The entire system of knowledge production in science and medicine needs to be overhauled to liberate it from the biases and distortions imposed by the pharmaceutical industry."
1:59

Toby Rogers, PhD gives a 360° explanation for why autism hasn't been studied correctly, as medicine, research, & regulation have all been captured by Big Pharma money. 🔥"Doctors live inside an epistemic bubble engineered by the pharmaceutical industry to increase its profits" Per Children's Health Defense: "Rogers is a fellow with the Brownstone Institute for Social and Economic Research. He has a doctorate in political economy from the University of Sydney in Australia, and a Master of Public Policy from the University of California, Berkeley." ---------------Partial transcription of clip-------------- "Let me explain how all this works. This is right in my wheelhouse. This is what I study. I follow the money. Autism is a political economy problem. These are all political economy problems. "Thus far, government has failed in response to the autism epidemic because of regulatory capture. Rather than protecting public health, regulators have advanced the interests of the pharmaceutical industry. That's pretty straightforward. Science and medicine have failed in response to the autism epidemic because of epistemic capture. And what I mean by that is that the pharmaceutical industry has captured every step in the knowledge production process in science and medicine. "Big Pharma controls what is studied, how it is researched, and what qualifies as evidence. Now, this capture permeates every level of the system. Medical textbooks and curricula are influenced by financially conflicted academics. Universities and department chairs hold substantial pharmaceutical ties. "Most clinical trials are conducted by for profit contract research organizations. In China and the third world, a large share of scientific journal articles are ghostwritten. The pharmaceutical industry spends over $27 billion annually on drug promotion and continuing medical education. Standards of care are, authored by conflicted physicians. So from the first day of medical school to the final years of practice, doctors live inside an epistemic bubble engineered by the pharmaceutical industry to increase its profits. "Senator Blumenthal and Dr. Scott only pay attention to captured science. Science that's controlled by the pharmaceutical industry. The correct answers, the best science is happening outside of that epistemic bubble. The entire system of knowledge production in science and medicine needs to be overhauled to liberate it from the biases and distortions imposed by the pharmaceutical industry."

Sense Receptor

110,680 görüntüleme • 10 ay önce

From LINACs to brachytherapy and dosimetry systems, the first public cancer centre in Malawi is now equipped to save lives, backed by @IAEAorg’s #RaysOfHope. A proud moment for 🇲🇼 and a step forward for cancer care in Africa.
1:29

From LINACs to brachytherapy and dosimetry systems, the first public cancer centre in Malawi is now equipped to save lives, backed by @IAEAorg’s #RaysOfHope. A proud moment for 🇲🇼 and a step forward for cancer care in Africa.

Rafael Mariano Grossi

10,721 görüntüleme • 1 yıl önce

"Fascism is a moment in the history of the middle-class, a means by which the middle-class protects itself from the working class." --- Bernardo Bertolucci on 'The Conformist' (1970) Full Excerpt: "'The Conformist' (1970) is first a film about the bourgeoisie, the middle-class, not about fascism. I was speaking about the middle class, and fascism is a moment in the history of the middle-class, a means by which the middle-class protects itself from the working class. Whenever the working class is coming up, up, up, at this moment fascism makes its appearance. In the film there is a fascist and an anti-fascist, but the Professor in Paris, the anti-fascist, is also from the middle-class. We have two faces of the same coin, of the middle-class. One face is fascism, the other is anti-fascism, but not a Marxist anti-fascism, just an idealism. Because he is also in the middle-class, my anti-fascist is not a hero, not a positive man." (From his interview with Joan Mellen, 1975)
3:00

"Fascism is a moment in the history of the middle-class, a means by which the middle-class protects itself from the working class." --- Bernardo Bertolucci on 'The Conformist' (1970) Full Excerpt: "'The Conformist' (1970) is first a film about the bourgeoisie, the middle-class, not about fascism. I was speaking about the middle class, and fascism is a moment in the history of the middle-class, a means by which the middle-class protects itself from the working class. Whenever the working class is coming up, up, up, at this moment fascism makes its appearance. In the film there is a fascist and an anti-fascist, but the Professor in Paris, the anti-fascist, is also from the middle-class. We have two faces of the same coin, of the middle-class. One face is fascism, the other is anti-fascism, but not a Marxist anti-fascism, just an idealism. Because he is also in the middle-class, my anti-fascist is not a hero, not a positive man." (From his interview with Joan Mellen, 1975)

DepressedBergman

69,770 görüntüleme • 2 yıl önce